Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T31101 |
CRT0273750
CRT 0273750,CRT-0273750 |
PDE | Metabolism |
CRT0273750 是一种 ATX 抑制剂的先导化合物,可调节血浆中 LPA 水平,用于 ATX/LPA 依赖性癌症模型。 | |||
T11533 |
Z-HA155
CS-963 |
PDE | Metabolism |
Z-HA155 (CS-963) 是一种高效的 ATX 选择性抑制剂,其 IC50=5.7 nM。 | |||
T70275 |
PAT-347
|
||
PAT-347 is a potent Autotaxin Inhibitor. Autotaxin (ATX) is a secreted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosphatidic acid (LPA) and choline. The ATX-LPA signaling pathway is implicated in cell survival, migration, and proliferation; thus, the inhibition of ATX is a recognized therapeutic target for a number of diseases including fibrotic diseases, cancer, and inflammation, among others. | |||
T14560 | BI-2545 | Others | Others |
BI-2545 is an autotaxin (ATX) inhibitor that significantly reduces LPA. For human ATX and rat ATX, the IC50s values are 2.2 nM and 3.4 nM , respectively. | |||
T28300 |
PAT-347 sodium
PAT-347,PAT347,PAT 347 |
||
PAT-347 is a potent inhibitor of Autotaxin (ATX), a secreted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosphatidic acid (LPA) and choline. |